✦ LIBER ✦

Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C

✍ Scribed by Shiro Akinaga; Kayo Nomura; Katsushige Gomi; Masami Okabe

Publisher: Springer
Year: 1993
Tongue: English
Weight: 728 KB
Volume: 32
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685833

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activity of a derivative of mi

Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(γ-l-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo

✍ Takashi Tsuruo; Yojiro Sudo; Noriko Asami; Makoto Inaba; Makoto Morimoto 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 516 KB

Antitumor effect of a baker's yeast mann

Antitumor effect of a baker's yeast mannan—mitomycin C conjugate against mouse hepatoma, MH134, in vivo and in vitro

✍ Kazuhiro Aizawa; Tatsuji Matsumoto; Keiko Tsukada; Akiko Ito; Hiromichi Sato; Sh 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 295 KB

A derivative of staurosporine (CGP 41 25

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti-proliferative as well as In vivo anti-tumor activity

✍ Thomas Meyer; Urs Regenass; Doriano Fabbro; Enrica Alteri; Johannes Röusel; Marc 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 632 KB

Analogues of staurosporine were synthesized and their ability to inhibit protein kinases was examined. Staurosporine is a potent but non-selective inhibitor of in vitro protein kinase C (PKC) activity (K5, 6.0 nn). The derivative CGP 41 25 I had reduced PKC activity with an IC,, of 50 nn but showed

Activation of Protein Kinase C in Vitro

Activation of Protein Kinase C in Vitro and in Intact Cells or Synaptosomes Determined by Acetic Acid Extraction of MARCKS

✍ P.J. Robinson; J.P. Liu; W. Chen; T. Wenzel 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 728 KB

MARCKS is a widespread cellular phosphoprotein that migrates at \(80-87 \mathrm{kDa}\) on polyacrylamide gels. It is phosphorylated apparently exclusively by protein kinase C (PKC) and its phosphorylation in intact cells can be used as an index of intracellular PKC activation. Most methods for the d

A potent protein-tyrosine kinase inhibit

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

✍ Nicholas B. Lydon; Helmut Mett; Marcel Mueller; Michael Becker; Robert M. Cozens 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

Antitumor activity of the selective epid

Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa® (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo

✍ Ichiro Naruse; Tohru Ohmori; Yoko Ao; Hisao Fukumoto; Toshio Kuroki; Masatomo Mo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 216 KB 👁 1 views

## Abstract Selective tyrosine kinase inhibitors are regarded as promising antitumor agents for cancer treatment. Iressa® (ZD1839) is an orally active, selective EGFR‐TKI (epidermal growth factor receptor‐tyrosine kinase inhibitor) that blocks signal transduction pathways implicated in cancer cell